US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Dec 31, 2018 (8 years ago)

Amlodipine and Valsartan Tablets USP 10 mg/320 mg. 30-count bottles, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

What was recalled

Amlodipine and Valsartan Tablets USP 10 mg/320 mg. 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-740-30.

Recalling firm
Aurobindo Pharma USA Inc.
NDC code
65862-740-30
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0364-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Valsartan recalls

See all